Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 99.58% is 35% above its 2-year average of 73.85%, around the middle of its 2-year range (39.73%–206.88%).
As of the fiscal period ended Tuesday, June 30, 2026. 33.72% above its 12-month average of 74.47%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 99.58%.
DEBT TO ASSETS RATIO
99.58%
DEBT TO ASSETS RATIO AVG TTM
74.47%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+33.72%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+110545.82%
vs the sector median at left
DataMEDS AI, Inc.
Market Cap
$8.37M
Debt to Assets Ratio
99.58%
TTM Avg
74.47%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.28M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.00M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.06M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.95M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.86M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DataMEDS AI, Inc. (MEDS) | $8.37M | 99.58% | 74.47% | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.28M | 1.07% | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.28M | 0.18% | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $8.13M | 0.00% | N/A | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.00M | 0.07% | N/A | N/A | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.06M | 0.02% | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.95M | 0.00% | N/A | N/A | N/A |
| Traws Pharma, Inc. (TRAW)vs › | $7.93M | 0.00% | N/A | N/A | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.86M | 0.05% | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.85M | 0.00% | N/A | N/A | N/A |
Debt/Assets
99.6%
Debt/Equity
N/A
Current Ratio
0.14
Interest Coverage
-17.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 99.58% |
| 2026-03-31 | 95.97% |
| 2025-12-31 | 81.31% |
| 2025-09-30 | 49.64% |
| 2025-06-30 | 45.86% |
| 2025-03-31 | 44.34% |
| 2024-12-31 | 43.80% |
| 2024-09-30 | 39.73% |
| 2024-06-30 | 52.05% |
| 2024-03-31 | 53.21% |
| 2023-12-31 | 206.88% |
